img

Global Sphingosine-1-Receptor Modulators Drugs Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Sphingosine-1-Receptor Modulators Drugs Market Insights, Forecast to 2034

Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
Global Sphingosine-1-Receptor Modulators Drugs market is expected to reach to US$ 4306.5 million in 2024, with a positive growth of %, compared with US$ 3983.6 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Sphingosine-1-Receptor Modulators Drugs industry is evaluated to reach US$ 6572.4 million in 2029. The CAGR will be 7.3% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Sphingosine-1-Receptor Modulators Drugs market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Sphingosine-1-Receptor Modulators Drugs market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Novartis
Bristol-Myers Squibb
Johnson & Johnson
Arena Pharmaceuticals
Idorsia
Sun Pharma
Biocon
HEC Pharm Co. Limited
Segment by Type
Fingolimod
Siponimod
Ozanimod
Other

Segment by Application


Hospital
Clinic
Other

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Sphingosine-1-Receptor Modulators Drugs plant distribution, commercial date of Sphingosine-1-Receptor Modulators Drugs, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Sphingosine-1-Receptor Modulators Drugs introduction, etc. Sphingosine-1-Receptor Modulators Drugs Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Sphingosine-1-Receptor Modulators Drugs
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Sphingosine-1-Receptor Modulators Drugs Product Introduction
1.2 Market by Type
1.2.1 Global Sphingosine-1-Receptor Modulators Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Fingolimod
1.2.3 Siponimod
1.2.4 Ozanimod
1.2.5 Other
1.3 Market by Application
1.3.1 Global Sphingosine-1-Receptor Modulators Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sphingosine-1-Receptor Modulators Drugs Sales Estimates and Forecasts 2018-2029
2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region
2.2.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2018-2024)
2.2.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2024-2029)
2.2.4 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2018-2029)
2.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Estimates and Forecasts 2018-2029
2.4 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region
2.4.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2018-2024)
2.4.3 Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2024-2029)
2.4.4 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Manufacturers
3.1.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Manufacturers (2018-2024)
3.1.2 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Sphingosine-1-Receptor Modulators Drugs in 2022
3.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Manufacturers
3.2.1 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Manufacturers (2018-2024)
3.2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Sphingosine-1-Receptor Modulators Drugs Revenue in 2022
3.3 Global Key Players of Sphingosine-1-Receptor Modulators Drugs, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Sphingosine-1-Receptor Modulators Drugs Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Sphingosine-1-Receptor Modulators Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Product Offered and Application
3.8 Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Type
4.1.1 Global Sphingosine-1-Receptor Modulators Drugs Historical Sales by Type (2018-2024)
4.1.2 Global Sphingosine-1-Receptor Modulators Drugs Forecasted Sales by Type (2024-2029)
4.1.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2018-2029)
4.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type
4.2.1 Global Sphingosine-1-Receptor Modulators Drugs Historical Revenue by Type (2018-2024)
4.2.2 Global Sphingosine-1-Receptor Modulators Drugs Forecasted Revenue by Type (2024-2029)
4.2.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2018-2029)
4.3 Global Sphingosine-1-Receptor Modulators Drugs Price by Type
4.3.1 Global Sphingosine-1-Receptor Modulators Drugs Price by Type (2018-2024)
4.3.2 Global Sphingosine-1-Receptor Modulators Drugs Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Sphingosine-1-Receptor Modulators Drugs Sales by Application
5.1.1 Global Sphingosine-1-Receptor Modulators Drugs Historical Sales by Application (2018-2024)
5.1.2 Global Sphingosine-1-Receptor Modulators Drugs Forecasted Sales by Application (2024-2029)
5.1.3 Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2018-2029)
5.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application
5.2.1 Global Sphingosine-1-Receptor Modulators Drugs Historical Revenue by Application (2018-2024)
5.2.2 Global Sphingosine-1-Receptor Modulators Drugs Forecasted Revenue by Application (2024-2029)
5.2.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2018-2029)
5.3 Global Sphingosine-1-Receptor Modulators Drugs Price by Application
5.3.1 Global Sphingosine-1-Receptor Modulators Drugs Price by Application (2018-2024)
5.3.2 Global Sphingosine-1-Receptor Modulators Drugs Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Sphingosine-1-Receptor Modulators Drugs Market Size by Type
6.1.1 US & Canada Sphingosine-1-Receptor Modulators Drugs Sales by Type (2018-2029)
6.1.2 US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2018-2029)
6.2 US & Canada Sphingosine-1-Receptor Modulators Drugs Market Size by Application
6.2.1 US & Canada Sphingosine-1-Receptor Modulators Drugs Sales by Application (2018-2029)
6.2.2 US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2018-2029)
6.3 US & Canada Sphingosine-1-Receptor Modulators Drugs Market Size by Country
6.3.1 US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Sphingosine-1-Receptor Modulators Drugs Sales by Country (2018-2029)
6.3.3 US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Sphingosine-1-Receptor Modulators Drugs Market Size by Type
7.1.1 Europe Sphingosine-1-Receptor Modulators Drugs Sales by Type (2018-2029)
7.1.2 Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2018-2029)
7.2 Europe Sphingosine-1-Receptor Modulators Drugs Market Size by Application
7.2.1 Europe Sphingosine-1-Receptor Modulators Drugs Sales by Application (2018-2029)
7.2.2 Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2018-2029)
7.3 Europe Sphingosine-1-Receptor Modulators Drugs Market Size by Country
7.3.1 Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2018-2029)
7.3.3 Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Sphingosine-1-Receptor Modulators Drugs Market Size
8.1.1 China Sphingosine-1-Receptor Modulators Drugs Sales (2018-2029)
8.1.2 China Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029)
8.2 China Sphingosine-1-Receptor Modulators Drugs Market Size by Application
8.2.1 China Sphingosine-1-Receptor Modulators Drugs Sales by Application (2018-2029)
8.2.2 China Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Sphingosine-1-Receptor Modulators Drugs Market Size by Type
9.1.1 Asia Sphingosine-1-Receptor Modulators Drugs Sales by Type (2018-2029)
9.1.2 Asia Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2018-2029)
9.2 Asia Sphingosine-1-Receptor Modulators Drugs Market Size by Application
9.2.1 Asia Sphingosine-1-Receptor Modulators Drugs Sales by Application (2018-2029)
9.2.2 Asia Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2018-2029)
9.3 Asia Sphingosine-1-Receptor Modulators Drugs Sales by Region
9.3.1 Asia Sphingosine-1-Receptor Modulators Drugs Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2018-2029)
9.3.3 Asia Sphingosine-1-Receptor Modulators Drugs Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Market Size by Type
10.1.1 Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Market Size by Application
10.2.1 Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Country
10.3.1 Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Information
11.1.2 Novartis Overview
11.1.3 Novartis Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Novartis Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Novartis Recent Developments
11.2 Bristol-Myers Squibb
11.2.1 Bristol-Myers Squibb Company Information
11.2.2 Bristol-Myers Squibb Overview
11.2.3 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bristol-Myers Squibb Recent Developments
11.3 Johnson & Johnson
11.3.1 Johnson & Johnson Company Information
11.3.2 Johnson & Johnson Overview
11.3.3 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Johnson & Johnson Recent Developments
11.4 Arena Pharmaceuticals
11.4.1 Arena Pharmaceuticals Company Information
11.4.2 Arena Pharmaceuticals Overview
11.4.3 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Arena Pharmaceuticals Recent Developments
11.5 Idorsia
11.5.1 Idorsia Company Information
11.5.2 Idorsia Overview
11.5.3 Idorsia Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Idorsia Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Idorsia Recent Developments
11.6 Sun Pharma
11.6.1 Sun Pharma Company Information
11.6.2 Sun Pharma Overview
11.6.3 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sun Pharma Recent Developments
11.7 Biocon
11.7.1 Biocon Company Information
11.7.2 Biocon Overview
11.7.3 Biocon Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Biocon Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Biocon Recent Developments
11.8 HEC Pharm Co. Limited
11.8.1 HEC Pharm Co. Limited Company Information
11.8.2 HEC Pharm Co. Limited Overview
11.8.3 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 HEC Pharm Co. Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Sphingosine-1-Receptor Modulators Drugs Industry Chain Analysis
12.2 Sphingosine-1-Receptor Modulators Drugs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Sphingosine-1-Receptor Modulators Drugs Production Mode & Process
12.4 Sphingosine-1-Receptor Modulators Drugs Sales and Marketing
12.4.1 Sphingosine-1-Receptor Modulators Drugs Sales Channels
12.4.2 Sphingosine-1-Receptor Modulators Drugs Distributors
12.5 Sphingosine-1-Receptor Modulators Drugs Customers
13 Market Dynamics
13.1 Sphingosine-1-Receptor Modulators Drugs Industry Trends
13.2 Sphingosine-1-Receptor Modulators Drugs Market Drivers
13.3 Sphingosine-1-Receptor Modulators Drugs Market Challenges
13.4 Sphingosine-1-Receptor Modulators Drugs Market Restraints
14 Key Findings in The Global Sphingosine-1-Receptor Modulators Drugs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Sphingosine-1-Receptor Modulators Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Fingolimod
Table 3. Major Manufacturers of Siponimod
Table 4. Major Manufacturers of Ozanimod
Table 5. Major Manufacturers of Other
Table 6. Global Sphingosine-1-Receptor Modulators Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 7. Global Sphingosine-1-Receptor Modulators Drugs Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 8. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 9. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 10. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2018-2024)
Table 11. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2024-2029)
Table 12. Global Sphingosine-1-Receptor Modulators Drugs Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 13. Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2018-2024) & (K Units)
Table 14. Global Sphingosine-1-Receptor Modulators Drugs Sales by Region (2024-2029) & (K Units)
Table 15. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2018-2024)
Table 16. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2024-2029)
Table 17. Global Sphingosine-1-Receptor Modulators Drugs Sales by Manufacturers (2018-2024) & (K Units)
Table 18. Global Sphingosine-1-Receptor Modulators Drugs Sales Share by Manufacturers (2018-2024)
Table 19. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 20. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Manufacturers (2018-2024)
Table 21. Global Key Players of Sphingosine-1-Receptor Modulators Drugs, Industry Ranking, 2021 VS 2022 VS 2024
Table 22. Sphingosine-1-Receptor Modulators Drugs Price by Manufacturers 2018-2024 (US$/Unit)
Table 23. Global Sphingosine-1-Receptor Modulators Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 24. Global Sphingosine-1-Receptor Modulators Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sphingosine-1-Receptor Modulators Drugs as of 2022)
Table 25. Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Manufacturing Base Distribution and Headquarters
Table 26. Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Product Offered and Application
Table 27. Global Key Manufacturers of Sphingosine-1-Receptor Modulators Drugs, Date of Enter into This Industry
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2018-2024) & (K Units)
Table 30. Global Sphingosine-1-Receptor Modulators Drugs Sales by Type (2024-2029) & (K Units)
Table 31. Global Sphingosine-1-Receptor Modulators Drugs Sales Share by Type (2018-2024)
Table 32. Global Sphingosine-1-Receptor Modulators Drugs Sales Share by Type (2024-2029)
Table 33. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 34. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 35. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Type (2018-2024)
Table 36. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Type (2024-2029)
Table 37. Sphingosine-1-Receptor Modulators Drugs Price by Type (2018-2024) & (US$/Unit)
Table 38. Global Sphingosine-1-Receptor Modulators Drugs Price Forecast by Type (2024-2029) & (US$/Unit)
Table 39. Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2018-2024) & (K Units)
Table 40. Global Sphingosine-1-Receptor Modulators Drugs Sales by Application (2024-2029) & (K Units)
Table 41. Global Sphingosine-1-Receptor Modulators Drugs Sales Share by Application (2018-2024)
Table 42. Global Sphingosine-1-Receptor Modulators Drugs Sales Share by Application (2024-2029)
Table 43. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 44. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 45. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Application (2018-2024)
Table 46. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Application (2024-2029)
Table 47. Sphingosine-1-Receptor Modulators Drugs Price by Application (2018-2024) & (US$/Unit)
Table 48. Global Sphingosine-1-Receptor Modulators Drugs Price Forecast by Application (2024-2029) & (US$/Unit)
Table 49. US & Canada Sphingosine-1-Receptor Modulators Drugs Sales by Type (2018-2024) & (K Units)
Table 50. US & Canada Sphingosine-1-Receptor Modulators Drugs Sales by Type (2024-2029) & (K Units)
Table 51. US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 52. US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 53. US & Canada Sphingosine-1-Receptor Modulators Drugs Sales by Application (2018-2024) & (K Units)
Table 54. US & Canada Sphingosine-1-Receptor Modulators Drugs Sales by Application (2024-2029) & (K Units)
Table 55. US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 56. US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 57. US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 58. US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 59. US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 60. US & Canada Sphingosine-1-Receptor Modulators Drugs Sales by Country (2018-2024) & (K Units)
Table 61. US & Canada Sphingosine-1-Receptor Modulators Drugs Sales by Country (2024-2029) & (K Units)
Table 62. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Type (2018-2024) & (K Units)
Table 63. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Type (2024-2029) & (K Units)
Table 64. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 65. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 66. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Application (2018-2024) & (K Units)
Table 67. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Application (2024-2029) & (K Units)
Table 68. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 69. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 70. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 71. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 72. Europe Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 73. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2018-2024) & (K Units)
Table 74. Europe Sphingosine-1-Receptor Modulators Drugs Sales by Country (2024-2029) & (K Units)
Table 75. China Sphingosine-1-Receptor Modulators Drugs Sales by Type (2018-2024) & (K Units)
Table 76. China Sphingosine-1-Receptor Modulators Drugs Sales by Type (2024-2029) & (K Units)
Table 77. China Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 78. China Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 79. China Sphingosine-1-Receptor Modulators Drugs Sales by Application (2018-2024) & (K Units)
Table 80. China Sphingosine-1-Receptor Modulators Drugs Sales by Application (2024-2029) & (K Units)
Table 81. China Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 82. China Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 83. Asia Sphingosine-1-Receptor Modulators Drugs Sales by Type (2018-2024) & (K Units)
Table 84. Asia Sphingosine-1-Receptor Modulators Drugs Sales by Type (2024-2029) & (K Units)
Table 85. Asia Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 86. Asia Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 87. Asia Sphingosine-1-Receptor Modulators Drugs Sales by Application (2018-2024) & (K Units)
Table 88. Asia Sphingosine-1-Receptor Modulators Drugs Sales by Application (2024-2029) & (K Units)
Table 89. Asia Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 90. Asia Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 91. Asia Sphingosine-1-Receptor Modulators Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 92. Asia Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2018-2024) & (US$ Million)
Table 93. Asia Sphingosine-1-Receptor Modulators Drugs Revenue by Region (2024-2029) & (US$ Million)
Table 94. Asia Sphingosine-1-Receptor Modulators Drugs Sales by Region (2018-2024) & (K Units)
Table 95. Asia Sphingosine-1-Receptor Modulators Drugs Sales by Region (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Type (2018-2024) & (K Units)
Table 97. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Type (2024-2029) & (K Units)
Table 98. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2018-2024) & (US$ Million)
Table 99. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Type (2024-2029) & (US$ Million)
Table 100. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Application (2018-2024) & (K Units)
Table 101. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Application (2024-2029) & (K Units)
Table 102. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2018-2024) & (US$ Million)
Table 103. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Application (2024-2029) & (US$ Million)
Table 104. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 105. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2018-2024) & (US$ Million)
Table 106. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue by Country (2024-2029) & (US$ Million)
Table 107. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2018-2024) & (K Units)
Table 108. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales by Country (2024-2029) & (K Units)
Table 109. Novartis Company Information
Table 110. Novartis Description and Major Businesses
Table 111. Novartis Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 112. Novartis Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 113. Novartis Recent Developments
Table 114. Bristol-Myers Squibb Company Information
Table 115. Bristol-Myers Squibb Description and Major Businesses
Table 116. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 117. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 118. Bristol-Myers Squibb Recent Developments
Table 119. Johnson & Johnson Company Information
Table 120. Johnson & Johnson Description and Major Businesses
Table 121. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 122. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 123. Johnson & Johnson Recent Developments
Table 124. Arena Pharmaceuticals Company Information
Table 125. Arena Pharmaceuticals Description and Major Businesses
Table 126. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 127. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 128. Arena Pharmaceuticals Recent Developments
Table 129. Idorsia Company Information
Table 130. Idorsia Description and Major Businesses
Table 131. Idorsia Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 132. Idorsia Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 133. Idorsia Recent Developments
Table 134. Sun Pharma Company Information
Table 135. Sun Pharma Description and Major Businesses
Table 136. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 137. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 138. Sun Pharma Recent Developments
Table 139. Biocon Company Information
Table 140. Biocon Description and Major Businesses
Table 141. Biocon Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 142. Biocon Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 143. Biocon Recent Developments
Table 144. HEC Pharm Co. Limited Company Information
Table 145. HEC Pharm Co. Limited Description and Major Businesses
Table 146. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 147. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Product Model Numbers, Pictures, Descriptions and Specifications
Table 148. HEC Pharm Co. Limited Recent Developments
Table 149. Key Raw Materials Lists
Table 150. Raw Materials Key Suppliers Lists
Table 151. Sphingosine-1-Receptor Modulators Drugs Distributors List
Table 152. Sphingosine-1-Receptor Modulators Drugs Customers List
Table 153. Sphingosine-1-Receptor Modulators Drugs Market Trends
Table 154. Sphingosine-1-Receptor Modulators Drugs Market Drivers
Table 155. Sphingosine-1-Receptor Modulators Drugs Market Challenges
Table 156. Sphingosine-1-Receptor Modulators Drugs Market Restraints
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Sphingosine-1-Receptor Modulators Drugs Product Picture
Figure 2. Global Sphingosine-1-Receptor Modulators Drugs Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Sphingosine-1-Receptor Modulators Drugs Market Share by Type in 2022 & 2029
Figure 4. Fingolimod Product Picture
Figure 5. Siponimod Product Picture
Figure 6. Ozanimod Product Picture
Figure 7. Other Product Picture
Figure 8. Global Sphingosine-1-Receptor Modulators Drugs Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 9. Global Sphingosine-1-Receptor Modulators Drugs Market Share by Application in 2022 & 2029
Figure 10. Hospital
Figure 11. Clinic
Figure 12. Other
Figure 13. Sphingosine-1-Receptor Modulators Drugs Report Years Considered
Figure 14. Global Sphingosine-1-Receptor Modulators Drugs Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Sphingosine-1-Receptor Modulators Drugs Revenue 2018-2029 (US$ Million)
Figure 16. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 17. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Region (2018-2029)
Figure 18. Global Sphingosine-1-Receptor Modulators Drugs Sales 2018-2029 ((K Units)
Figure 19. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Region (2018-2029)
Figure 20. US & Canada Sphingosine-1-Receptor Modulators Drugs Sales YoY (2018-2029) & (K Units)
Figure 21. US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 22. Europe Sphingosine-1-Receptor Modulators Drugs Sales YoY (2018-2029) & (K Units)
Figure 23. Europe Sphingosine-1-Receptor Modulators Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 24. China Sphingosine-1-Receptor Modulators Drugs Sales YoY (2018-2029) & (K Units)
Figure 25. China Sphingosine-1-Receptor Modulators Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Asia (excluding China) Sphingosine-1-Receptor Modulators Drugs Sales YoY (2018-2029) & (K Units)
Figure 27. Asia (excluding China) Sphingosine-1-Receptor Modulators Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales YoY (2018-2029) & (K Units)
Figure 29. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue YoY (2018-2029) & (US$ Million)
Figure 30. The Sphingosine-1-Receptor Modulators Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 31. The Top 5 and 10 Largest Manufacturers of Sphingosine-1-Receptor Modulators Drugs in the World: Market Share by Sphingosine-1-Receptor Modulators Drugs Revenue in 2022
Figure 32. Global Sphingosine-1-Receptor Modulators Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 33. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2018-2029)
Figure 34. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2018-2029)
Figure 35. Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2018-2029)
Figure 36. Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2018-2029)
Figure 37. US & Canada Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2018-2029)
Figure 38. US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2018-2029)
Figure 39. US & Canada Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2018-2029)
Figure 40. US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2018-2029)
Figure 41. US & Canada Sphingosine-1-Receptor Modulators Drugs Revenue Share by Country (2018-2029)
Figure 42. US & Canada Sphingosine-1-Receptor Modulators Drugs Sales Share by Country (2018-2029)
Figure 43. U.S. Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 44. Canada Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 45. Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2018-2029)
Figure 46. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2018-2029)
Figure 47. Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2018-2029)
Figure 48. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2018-2029)
Figure 49. Europe Sphingosine-1-Receptor Modulators Drugs Revenue Share by Country (2018-2029)
Figure 50. Europe Sphingosine-1-Receptor Modulators Drugs Sales Share by Country (2018-2029)
Figure 51. Germany Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 52. France Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 53. U.K. Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 54. Italy Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 55. Russia Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 56. China Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2018-2029)
Figure 57. China Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2018-2029)
Figure 58. China Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2018-2029)
Figure 59. China Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2018-2029)
Figure 60. Asia Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2018-2029)
Figure 61. Asia Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2018-2029)
Figure 62. Asia Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2018-2029)
Figure 63. Asia Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2018-2029)
Figure 64. Asia Sphingosine-1-Receptor Modulators Drugs Revenue Share by Region (2018-2029)
Figure 65. Asia Sphingosine-1-Receptor Modulators Drugs Sales Share by Region (2018-2029)
Figure 66. Japan Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 67. South Korea Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 68. China Taiwan Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 69. Southeast Asia Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 70. India Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 71. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Type (2018-2029)
Figure 72. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Type (2018-2029)
Figure 73. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales Market Share by Application (2018-2029)
Figure 74. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue Market Share by Application (2018-2029)
Figure 75. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Revenue Share by Country (2018-2029)
Figure 76. Middle East, Africa and Latin America Sphingosine-1-Receptor Modulators Drugs Sales Share by Country (2018-2029)
Figure 77. Brazil Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 78. Mexico Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 79. Turkey Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 80. Israel Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 81. GCC Countries Sphingosine-1-Receptor Modulators Drugs Revenue (2018-2029) & (US$ Million)
Figure 82. Sphingosine-1-Receptor Modulators Drugs Value Chain
Figure 83. Sphingosine-1-Receptor Modulators Drugs Production Process
Figure 84. Channels of Distribution
Figure 85. Distributors Profiles
Figure 86. Bottom-up and Top-down Approaches for This Report
Figure 87. Data Triangulation
Figure 88. Key Executives Interviewed